No Data
No Data
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Sunshine Biopharma Announces Canadian Subsidiary Nora Pharma Acquired Two Gastrointestinal Drugs; Launches Prucalopride For Chronic Constipation, Second Drug Launch Planned in 9 Months. Gastrointestinal Market Worth In Excess Of C$200M Per Year.
Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market
Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT
Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer
102539778 : appreciate you good sir
72055196 : when company annouce delisting why price starts increasing of that particul stock?? please answerr @Jaguar8
Jaguar8 OP 72055196 : its a delisting PR pump
Trademark-17 : when is be the pumping and how much it's be going high?
na2a : What is the indicator you use to shortlist possible momentum stock?
View more comments...